SG42865A1 - Therapeutic compositions and methods - Google Patents
Therapeutic compositions and methodsInfo
- Publication number
- SG42865A1 SG42865A1 SG1996000279A SG1996000279A SG42865A1 SG 42865 A1 SG42865 A1 SG 42865A1 SG 1996000279 A SG1996000279 A SG 1996000279A SG 1996000279 A SG1996000279 A SG 1996000279A SG 42865 A1 SG42865 A1 SG 42865A1
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- therapeutic compositions
- therapeutic
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPK739891 | 1991-07-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG42865A1 true SG42865A1 (en) | 1997-10-17 |
Family
ID=3775574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996000279A SG42865A1 (en) | 1991-07-24 | 1992-07-23 | Therapeutic compositions and methods |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5484609A (fr) |
| EP (1) | EP0596962A4 (fr) |
| JP (1) | JPH06511237A (fr) |
| CA (1) | CA2114122A1 (fr) |
| HU (1) | HUT67007A (fr) |
| NZ (1) | NZ243722A (fr) |
| RU (1) | RU2113220C1 (fr) |
| SG (1) | SG42865A1 (fr) |
| WO (1) | WO1993001800A1 (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0671943T3 (da) * | 1992-06-30 | 2000-03-27 | Cortecs Uk Ltd | Anvendelse af enzymer, især bromelain, i behandlingen af ikke-infektiøs diarré |
| US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
| US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
| GB9313188D0 (en) * | 1993-06-25 | 1993-08-11 | Cortecs Ltd | Medical use of enzymes |
| US6183778B1 (en) | 1993-09-21 | 2001-02-06 | Jagotec Ag | Pharmaceutical tablet capable of liberating one or more drugs at different release rates |
| GB9409336D0 (en) * | 1994-05-10 | 1994-06-29 | Finnfeeds Int Ltd | Use of an enzyme for manufacturing an agent for the treatment and/or prophylaxis of coccidiosis |
| US5750496A (en) * | 1996-08-12 | 1998-05-12 | Utah State University | Method of controlling cryptosporidium infectons using protease inhibitors |
| DE59702733D1 (de) | 1996-08-15 | 2001-01-11 | Losan Pharma Gmbh | Gut schluckbare orale arzneiform |
| US20020102253A1 (en) | 1997-02-25 | 2002-08-01 | Mynott Tracey Lehanne | Component of bromelain |
| EP1012305A1 (fr) | 1997-02-25 | 2000-06-28 | Cortecs (UK) Limited | Composant de la bromeline |
| GB2327345B (en) | 1997-07-18 | 1999-06-23 | Finnfeeds Int Ltd | Use of an enzyme for manufacturing an agent for controlling bacterial infection |
| US7257604B1 (en) | 1997-11-17 | 2007-08-14 | Wolfe Mark A | System and method for communicating information relating to a network resource |
| TR200002059T2 (tr) * | 1998-01-16 | 2001-01-22 | Takeda Chemical Industries, Ltd. | Devamlı salınan bileşim, üretim yöntemi ve kullanımı. |
| DE69916031T2 (de) * | 1998-01-29 | 2005-02-17 | Poly-Med Inc. | Asorbierbare mikropartikel |
| GB2358135A (en) * | 1999-12-09 | 2001-07-18 | Finnfeeds Int Ltd | Animal feed additives comprising betaine and a protease |
| UA78486C2 (uk) * | 1999-12-10 | 2007-04-10 | Хемджен Корпорейшн | Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти) |
| EP1366761A4 (fr) * | 2001-02-13 | 2004-04-21 | Taisho Pharmaceutical Co Ltd | Preparations de gel a usage interne |
| US7316819B2 (en) * | 2001-03-08 | 2008-01-08 | Unigene Laboratories, Inc. | Oral peptide pharmaceutical dosage form and method of production |
| US20040097720A1 (en) * | 2001-04-02 | 2004-05-20 | Bott Richard R. | Use of glycodendrimer reagents for inhibiting adhesion by microorganisms |
| RU2213557C2 (ru) * | 2001-12-26 | 2003-10-10 | Закрытое акционерное общество "Аксис" | Фармацевтическая композиция, обладающая тромболитическими, противовоспалительными и цитопротективными свойствами |
| RU2229128C2 (ru) * | 2002-06-28 | 2004-05-20 | Российский государственный медицинский университет | Способ диагностики криптоспоридиоза |
| MXPA05000128A (es) * | 2002-07-05 | 2005-09-30 | Temrel Inc | Composicion de liberacion controlada. |
| RU2440369C2 (ru) * | 2007-08-03 | 2012-01-20 | Бёрингер Ингельхайм Ветмедика Гмбх | ГЕНЫ И БЕЛКИ Brachyspira hyodysenteriae И ИХ ПРИМЕНЕНИЕ |
| AU2012326513B2 (en) * | 2011-10-19 | 2016-03-17 | R.P. Scherer Technologies, Llc | Two phase pharmaceutical delivery system |
| GB201311272D0 (en) | 2013-06-25 | 2013-08-14 | Ucl Business Plc | Anti-microbial agents and uses thereof |
| CA2959361A1 (fr) * | 2014-08-25 | 2016-03-03 | Anatara Lifesciences Limited | Formulation anti-diarrheique evitant la resistance aux antimicrobiens |
| US20210008180A1 (en) * | 2018-02-23 | 2021-01-14 | MUCPharm Pty Ltd | Formulations containing mucin-affecting proteases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1435905A (en) * | 1972-11-03 | 1976-05-19 | Unilever Ltd | Enzyme granules |
| US3946110A (en) * | 1974-05-30 | 1976-03-23 | Peter, Strong Research And Development Company, Inc. | Medicinal compositions and methods of preparing the same |
| US4014334A (en) * | 1976-02-02 | 1977-03-29 | Alza Corporation | Laminated osmotic system for dispensing beneficial agent |
| US4299613A (en) * | 1979-02-22 | 1981-11-10 | Environmental Chemicals, Inc. | Controlled release of trace nutrients |
| US4400374A (en) * | 1979-06-22 | 1983-08-23 | Environmental Chemicals, Inc. | Controlled release of compounds utilizing a plastic matrix |
| JPS5659707A (en) * | 1979-10-19 | 1981-05-23 | Toyo Jozo Co Ltd | Lasting antibiotic pharmaceutical and its preparation |
| US4432968A (en) * | 1980-10-20 | 1984-02-21 | The Dow Chemical Company | Weight control with fat imbibing polymers |
| NZ203684A (en) * | 1982-04-05 | 1986-06-11 | Merck Sharp & Dohme | Granular formulation for the stabilization of unstable drugs or food supplements |
| US4629621A (en) * | 1984-07-23 | 1986-12-16 | Zetachron, Inc. | Erodible matrix for sustained release bioactive composition |
| PH27186A (en) * | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
-
1992
- 1992-07-23 RU RU94016167A patent/RU2113220C1/ru active
- 1992-07-23 CA CA002114122A patent/CA2114122A1/fr not_active Abandoned
- 1992-07-23 WO PCT/AU1992/000371 patent/WO1993001800A1/fr not_active Ceased
- 1992-07-23 SG SG1996000279A patent/SG42865A1/en unknown
- 1992-07-23 EP EP92916311A patent/EP0596962A4/en not_active Ceased
- 1992-07-23 JP JP5502489A patent/JPH06511237A/ja active Pending
- 1992-07-23 HU HU9400190A patent/HUT67007A/hu unknown
- 1992-07-24 NZ NZ243722A patent/NZ243722A/en unknown
-
1994
- 1994-01-21 US US08/185,061 patent/US5484609A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HU9400190D0 (en) | 1994-05-30 |
| CA2114122A1 (fr) | 1993-02-04 |
| RU2113220C1 (ru) | 1998-06-20 |
| EP0596962A1 (fr) | 1994-05-18 |
| EP0596962A4 (en) | 1997-01-15 |
| RU94016167A (ru) | 1996-04-10 |
| WO1993001800A1 (fr) | 1993-02-04 |
| HUT67007A (en) | 1995-01-30 |
| JPH06511237A (ja) | 1994-12-15 |
| NZ243722A (en) | 1994-09-27 |
| US5484609A (en) | 1996-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG42865A1 (en) | Therapeutic compositions and methods | |
| AP9100258A0 (en) | Synergistic therapeutic compositions and methods | |
| IL106109A0 (en) | Vaccine compositions and their manufacture | |
| GB9121289D0 (en) | Composition and use | |
| ZA945653B (en) | Therapeutic compositions | |
| EP0591303A4 (en) | Methods and compositions for treating malaria and other diseases | |
| GB2294637B (en) | Therapeutic compositions and methods of use | |
| ZA924491B (en) | Compositions and use thereof | |
| GB9007730D0 (en) | Therapeutic compound and composition | |
| ZA921137B (en) | Composition and use | |
| EP0505941A3 (en) | Peptifluorin and neopeptifluorin | |
| GB9326395D0 (en) | Therapeutic methods and compositions | |
| HK1004190A (en) | Therapeutic compositions and methods | |
| GB9113011D0 (en) | Novel treatment and compositions | |
| GB9113039D0 (en) | Novel treatment and compositions | |
| GB9113042D0 (en) | Novel treatment and compositions | |
| GB9113038D0 (en) | Novel treatment and compositions | |
| ZA925237B (en) | Substituted 1-phenyl-1-benzoylamino-5-aminopentanes their preparation and use | |
| GB9109973D0 (en) | Therapeutic compositions | |
| GB9113041D0 (en) | Novel treatments and compositions | |
| GB9113040D0 (en) | Novel treatments and compositions | |
| GB9214591D0 (en) | Therapeutic composition | |
| GB9116906D0 (en) | Composition and use | |
| EG19704A (en) | Therapeutic agents | |
| GB9108675D0 (en) | Pharmaceutical method and compositions |